Skip to main content
S&P 5007,376.86+0.31%DOW51,285.73-0.46%NASDAQ24,579.42+1.09%BTC$75,946.00-0.25%ETH$2,243.57+0.21%GOLD$4,079.50-0.83%OIL$90.34-0.20%
Smart Investors Daily
SID Premium
MM

NASDAQ · MMTXU

Miluna Acquisition Corp

Financial Services · Shell Companies

$10.49

Up+$0.13 (+1.25%)

Updated Nov 8, 2026, 2:08 PM

SID Score

4.7/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
76.98M
P/E ratio
—
Dividend yield
—
52-week range
$10.00 – $11.17
Volume
2.29K
Avg. volume
105.51K

Price performance · MMTXU

MMTXU price history

1M range · 11 trading sessions · Daily adjusted prices

Prices through Nov 6, 2026

MMTXU closed at $10.49 after 11 trading sessions, up 1.84% for the selected period.

Last close
$10.49
Period change
+1.84%
Period low
$10.30
Period high
$10.49
Daily close
View OHLC price history
MMTXU OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 6, 2026$10.45$10.95$10.40$10.492.29K
Nov 5, 2026$10.75$10.78$10.35$10.363.51K
Nov 4, 2026$10.72$10.80$10.34$10.341.79K
Nov 3, 2026$10.69$10.69$10.45$10.451.17K
Nov 2, 2026$10.65$10.65$10.46$10.461.4K
Oct 30, 2026$10.72$10.72$10.40$10.452.38K
Oct 29, 2026$10.72$10.72$10.40$10.401.01K
Oct 28, 2026$10.78$10.78$10.40$10.401.42K
Oct 27, 2026$10.80$10.80$10.30$10.301.44K
Oct 26, 2026$10.76$10.76$10.30$10.301.21K
Oct 23, 2026$10.40$10.70$10.30$10.30704

Latest MMTXU news

The latest Smart Investors Daily articles mentioning MMTXU.

Stock researchCompany · Overview

MMTXU research

Overview

Company profile and research snapshot.

Company profile

Miluna Acquisition Corp is a blank check company.

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Apr 7, 2026

Edison Issues Report on MindMaze Therapeutics (MMTX)

London, United Kingdom--(Newsfile Corp. - April 7, 2026) - Edison issues report on MindMaze Therapeutics (SIX: MMTX).MindMaze Therapeutics is a commercial-stage health technology company pioneering AI-driven digital neurotherapeutic solutions for treatment and recovery after neurological events such as stroke and traumatic brain injury (TBI). Its unique, integrated and coordinated platform spans the full continuum of care from acute treatment to at-home recovery, providing differentiation and...

globenewswire.com · Oct 28, 2025

Miluna Acquisition Corp Announces Closing of Full Underwriters' Over-Allotment Option in connection with its Initial Public Offering

Taipei, Taiwan., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Miluna Acquisition Corp (Nasdaq: MMTXU) (the “Company”), a Cayman Islands exempted company, announced today that the underwriters of its previously announced initial public offering fully exercised the over-allotment option to purchase an additional 900,000 units at the public offering price of $10.00 per unit, resulting in additional gross proceeds of $9,000,000. After giving effect to this full exercise of the over-allotment option, the total number of units sold in the public offering increased to 6,900,000, resulting in an aggregate gross proceeds of $69,000,000 for the Company's initial public offering. The units began trading on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol “MMTXU” on October 23, 2025. Each unit consists of one (1) ordinary share and one (1) redeemable warrant. Once the securities comprising the units begin separate trading, the ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “MMTX” and “MMTXW”, respectively.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By